All In Biotech

Drug Trial Radar · NCT02633046

Acthar for Treatment-Resistant or Treatment-Intolerant Proteinuria

Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic Focal Segmental Glomerulosclerosis: A Prospective Study of Acthar (PODOCYTE)

Last checked: Nov 20, 2026Latest source record: Aug 4, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

63

Actual

Start

Oct 10, 2016

Primary completion

Aug 27, 2020

Study completion Aug 27, 2020

Sponsor

Lead sponsor
Mallinckrodt ARD LLCIndustry
Sponsor type
Industry
First posted
Dec 17, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Focal segmental glomerulosclerosis (FSGS) is a condition that harms the kidney "filters" that remove waste from the blood. Proteins are supposed to stay in the blood. Damaged "filters" let protein get into the kidney. FSGS is a serious condition that can lead to kidney failure. The only treatment for kidney failure is dialysis or kidney transplant. Proteinuria means too much protein came through the kidneys into the urine. If the doctor cannot figure out what is causing the problem, it is primary (idiopathic) FSGS. This kind of FSGS is very hard to treat. This study will test Acthar in patients with this condition who have not responded to other treatments. It primarily investigates how well the therapy is tolerated by the patients and how well they respond to this treatment.

Conditions

  • Idiopathic Focal Segmental Glomerulosclerosis

Interventions

  • Acthar GelDrug

    Acthar Gel 80 U/mL solution for subcutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Adverse EventsTime frame: within 56 weeks

Locations

47 sites in 7 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • AKDHC Medical Research Services, LLC

    Tucson, Arizona

  • California Institute of Renal Research

    Chula Vista, California

  • Stanford University

    Stanford, California

  • VERITAS Research Corp

    Miami Lakes, Florida

  • Genesis Clinical Research Corp

    Tampa, Florida

  • GA Nephrology

    Lawrenceville, Georgia

  • NANI Research

    Hinsdale, Illinois

  • University of Louisville Research Foundation, Inc.

    Louisville, Kentucky

  • Ochsner Clinic Foundation, Baton Rouge

    Baton Rouge, Louisiana

  • NKDHC Medical Research Services, LLC

    Las Vegas, Nevada

  • Icahn School of Medicine-Mt. Sinai

    New York, New York

  • Columbia University Medical Center

    New York, New York

  • Metrolina Nephrology Associates

    Charlotte, North Carolina

  • Brookview Hills Research Associates, LLC

    Winston-Salem, North Carolina

  • University of Cincinnati Physicians Company, LLC

    Cincinnati, Ohio

  • Cincinnati VA Medical Center

    Cincinnati, Ohio

  • Medical University of South Carolina

    Charleston, South Carolina

  • Texas Tech University Health Science Center

    Amarillo, Texas

  • Texas Kidney Institute (Neprhotex Research Group)

    Dallas, Texas

  • University of Wisconsin Wisconsin Dialysis Institute

    Madison, Wisconsin

  • Sanatorio Allende

    Córdoba, Argentina

  • Centro de Salud Renal Junín SRL

    Junín, Buenos Aires, Argentina

  • Centro de Investigaciones Médicas

    Mar del Plata, Buenos Aires, Argentina

  • Renal Research Group

    Gosford, New South Wales, Australia

  • Liverpool Hospital

    Liverpool, New South Wales, Australia

  • Westmead Hospita

    Westmead, New South Wales, Australia

  • Royal Brisbane and Women's Hospital

    Herston, Queensland, Australia

  • Launceston Hospital

    Launceston, Tasmania, Australia

  • The Alfred Hospital

    Melbourne, Victoria, Australia

  • Sunshine Hopital - Western Health

    St Albans, Victoria, Australia

  • Hospital Dr. Hernán Henríquez Aravena

    Temuco, Araucania, Chile

  • Clinica Davila

    Santiago, RM, Chile

  • Investigación Nefrológica SC

    Cuernavaca, Morelos, Mexico

  • Hospital y Clínica OCA S.A de C.V

    Monterrey, Nuevo León, Mexico

  • Hospital Nacional Alberto Sabogal

    Lima, Peru

  • Hospital Nacional Arzobispo Loayza

    Lima, Peru

  • Hospital Nacional Hospital Maria Auxiliadora

    Lima Lima, Peru

  • Hospital Nacional Cayetano Heredia

    San Martín de Porres, Lima region, Peru

  • Ankara NumuneTraining and Research Hospital

    Ankara, Turkey (Türkiye)

Showing 40 of 47 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.